COMMUNIQUÉS West-GlobeNewswire

XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

07/03/2018 - 22:05

Transformed business model to a royalty aggregator with extensive asset portfolio and capital; Added nine new partner-funded programs in 2017 with potential for milestone and royalty payments; Current cash balance [...]

Crinetics Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference

07/03/2018 - 22:05

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D [...]

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial Results

07/03/2018 - 22:05

WARSAW, Ind., March 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth [...]

Checkpoint Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

07/03/2018 - 22:05

NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq: CKPT ), a Fortress Biotech (Nasdaq: FBIO ) company, today announced that it is proposing to offer and [...]

Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results

07/03/2018 - 22:05

GAITHERSBURG, Md., March 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results [...]

AIT Therapeutics to Present at Two Investor Conferences

07/03/2018 - 22:05

REHOVOT, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]

HTG Molecular Diagnostics to Announce Fourth Quarter and Year-End Financial Results and Host Conference Call on Thursday, March 22

07/03/2018 - 22:01

TUCSON, Ariz., March 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will [...]

Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March

07/03/2018 - 22:01

BOSTON, March 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of [...]

Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update

07/03/2018 - 22:01

Xtampza ER prescriptions grew by 37% in the fourth quarter FDA Approval of sNDA, including Comparative OxyContin Data in label Expanded product portfolio by licensing rights to commercialize Nucynta franchise Revenue [...]

Trevena to Present at the Cowen and Company 38th Annual Healthcare Conference

07/03/2018 - 22:01

CHESTERBROOK, Pa., March 07, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018, at [...]

Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

07/03/2018 - 22:01

NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Celldex Provides Corporate Update and Reports Full Year 2017 Results

07/03/2018 - 22:01

HAMPTON, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the fourth quarter and year ended December 31, 2017. The Company will [...]

Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update

07/03/2018 - 22:01

Two novel anti-epileptic drugs advancing in clinical development; Interim XEN1101 Phase 1 data expected to be released in May 2018 at scientific symposium; Xenon announces new clinical stage ion channel product to [...]

Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference

07/03/2018 - 22:01

BERKELEY, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Andrea van Elsas, chief scientific officer of Aduro, will present at the 38th Annual Cowen Healthcare [...]

REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results

07/03/2018 - 21:50

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results [...]

Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR

07/03/2018 - 21:16

Company Release no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07 March 2018 Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR® Veloxis Pharmaceuticals A/S announced today that it has [...]

Vitrea® Intelligence Enables Imaging Queensland to Optimize Operations Across its Enterprise

07/03/2018 - 20:34

MINNETONKA, Minn., March 07, 2018 (GLOBE NEWSWIRE) -- Vital Images announced today that its enterprise analytics solution, Vitrea Intelligence, will be deployed at Imaging Queensland, a premier imaging network in [...]

Sanofi: Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report

07/03/2018 - 20:14

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report PARIS, France - March 7, 2018 - Sanofi announces [...]

Sanofi : Dépôt du Document de Référence 2017, contenant le Rapport Financier Annuel, et du « Form 20-F » américain

07/03/2018 - 20:14

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Dépôt du Document de Référence 2017, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris (France) - Le 7 mars 2018 - Sanofi [...]